Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP

MLA

Bernard, Sophie, et al. “Incidence of Central Nervous System Relapses in Patients with DLBCL Treated with Lenalidomide as Maintenance after R-CHOP.” Blood Advances, vol. 5, no. 15, Aug. 2021, pp. 2965–68. EBSCOhost, https://doi.org/10.1182/bloodadvances.2021004766.

APA

Bernard, S., Ghesquieres, H., Casasnovas, R.-O., Griolet, S., Gomes da Silva, M., Feugier, P., Morschhauser, F., Trotman, J., Renaud, L., Greil, R., García-Sancho, A. M., Grosicki, S., van Eygen, K., Copie-Bergman, C., Haioun, C., & Thieblemont, C. (2021). Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP. Blood Advances, 5(15), 2965–2968. https://doi.org/10.1182/bloodadvances.2021004766

Chicago

Bernard, Sophie, Herve Ghesquieres, Rene-Olivier Casasnovas, Samuel Griolet, Maria Gomes da Silva, Pierre Feugier, Franck Morschhauser, et al. 2021. “Incidence of Central Nervous System Relapses in Patients with DLBCL Treated with Lenalidomide as Maintenance after R-CHOP.” Blood Advances 5 (15): 2965–68. doi:10.1182/bloodadvances.2021004766.